Why Is Blood Donation Unpaid? An Argument About What Payment Does
By the BrainSnail editorial team. How these articles are written and checked, and how to tell us when one is wrong.
Most economic reasoning says that paying for something produces more of it. Whole blood donation in many countries is unpaid anyway, deliberately, on the argument that payment would reduce both the quantity and the safety of the supply. That claim was made in 1970, became one of the most cited arguments in social policy, and has since been tested repeatedly with results that are more complicated than either side wanted.
The original argument
Richard Titmuss, a British social policy professor, published The Gift Relationship in 1970, comparing the voluntary British blood system with the largely commercial American one. His empirical claims were that the American system produced more contaminated blood, wasted more, was more expensive and served patients worse. His theoretical claim was more interesting and more contested: that introducing payment does not simply add a financial motive to an existing altruistic one but destroys the altruistic motive, because the act changes meaning. Giving blood as a gift to strangers is an expression of social solidarity, and selling it is a transaction, so the people who gave freely stop and are replaced by people who need money, who are on average poorer, less healthy and have stronger incentives to conceal disqualifying information. The safety argument was particularly powerful in an era before reliable testing, when a donor's honesty about their own risk factors was the primary safeguard.
What the evidence has shown
The claim that incentives can reduce a desired behaviour has become a substantial research area, and blood is its founding case:
- •Motivation crowding out is real and documented in several settings, including a famous study in which fining parents for collecting children late from nursery increased lateness, because a fine converted a social obligation into a purchasable service
- •Field experiments on blood donation have produced mixed results, with some finding that cash offers reduce donation, particularly among women, and others finding modest increases
- •Non-cash incentives such as time off work, vouchers, small gifts and recognition generally increase donation without the negative effects attributed to cash
- •The safety argument has weakened considerably, since every unit is now tested for major transfusion-transmitted infections with highly sensitive methods, which reduces though does not eliminate reliance on donor honesty during the window period before an infection becomes detectable
- •Crowding out appears strongest where the behaviour is publicly visible and identity-related, which fits the theory that payment changes what the act signals about the donor
- •The United Nations health agency continues to recommend fully voluntary unpaid donation as the goal, on both safety and supply grounds
The plasma exception
The clearest complication is that the world does not in fact run on unpaid donation. Plasma, the liquid component used to manufacture medicines including immunoglobulins and clotting factors, is collected in much larger volumes and much more frequently than whole blood, through a process that returns the red cells to the donor. Demand for plasma-derived medicines has grown steadily, and the countries that permit payment, principally the United States along with a few others, supply the large majority of the world's plasma, including most of what unpaid-donation countries import for their own patients. That creates an uncomfortable position in which a country maintains a voluntary domestic system while depending on a paid system elsewhere, a point critics raise and which has prompted several countries to reconsider. The industrial nature of plasma collection also differs from the whole blood case in ways that matter to the argument: it is repeated, time-consuming, closer to work than to a gift, and the product is a manufacturing input rather than a unit transfused directly to a patient.
What it says about incentives generally
The lasting contribution of the debate is not the specific policy but the demonstration that incentives operate on meaning as well as on price. A payment carries information: about what the payer thinks the act is worth, about whether the act is a favour or a job, and about what kind of person does it. Where an activity is sustained by identity and social approval, adding money can substitute a weaker motive for a stronger one and reduce supply. That reasoning has since been applied to organ donation, to volunteering, to nuclear waste siting, where compensation offers reduced acceptance in a well-known Swiss study, and to workplace incentives. It does not generalise to everything, since payment plainly increases the supply of most goods and most labour, and the useful question is which category a particular activity belongs to. The practical settlement in blood policy reflects that: no cash, and an elaborate apparatus of recognition, convenience, time off and thanks, which raises donation without converting the gift into a sale.
The takeaway
Titmuss argued in 1970 that paying for blood destroys the altruistic motive rather than adding to it, and attracts donors with reasons to conceal health risks, which mattered more before reliable testing. Research since has confirmed that incentives can crowd out socially motivated behaviour, with cash offers sometimes reducing donation while non-cash recognition raises it. The awkward fact is that plasma, collected in far larger volumes, comes mostly from paid donors in a few countries and is imported by unpaid-donation systems.